View
1
Download
0
Category
Preview:
Citation preview
1
“PROF. DR. ION CHIRICUŢĂ” ONCOLOGY INSTITUTE
INTERNATIONAL CONFERENCE
FIRST CONFERENCE OF THE ROMANIAN DIVISION OF IAP
“THE PATHOBIOLOGY AND MOLECULAR BIOLOGY OF TUMORS”
CLUJ-NAPOCA ROMANIA28-30 APRIL, 2010
City Plaza Hotel
DETAILED PROGRAMME
2
TUESDAY, APRIL 27, 2010
16.00 – 18.00
REGISTRATION / CITY PLAZA HOTEL /MAIN LOBBY
WEDNESDAY, APRIL 28, 2010
7.30 – 8.45
REGISTRATION / CITY PLAZA HOTEL /MAIN LOBBY/POSTER MOUNTING
9.00 – 10.00
OFFICIAL OPENING CEREMONY
CITY PLAZA BALLROOM9.00 – 9.10
ALEXANDRU IRIMIE“PROF. DR. ION CHIRICUŢĂ” ONCOLOGY INSTITUTE, CLUJ-NAPOCA, ROMANIA – A POWERFUL CENTER IN PATHOLOGY
AND THERAPY OF CANCER
9.10 – 9.20
CLAUDIO LOMBARDO INAUGURAL FROM THE ORGANISATION OF THE EUROPEAN CANCER INSTITUTES
9.20 – 9.30
PETRE FLORESCUCONTINUOS MEDICAL EDUCATION – OR HOW TO BECOME A PROFESSIONIST IN PATHOLOGY
9.30 – 9.40
ANTONIO LLOMBART-BOSCHPATHOBIOLOGY WORKING GROUP – EXCELLENCE IN CANCER BIOLOGY AND TREATMENT
9.40 – 9.50
MARIA SAJINTHE MISSION OF THE ROMANIAN DIVISION OF IAP
9.50 – 10.00
ARETI DINULESCUTHE ROMANIAN SOCIETY OF PATHOLOGY: NEW CHALLENGES IN THE YEARS TO COME
10.00 – 10.20 / COFFEE BREAK
10.20 – 12.20 PLENARY SESSION I / CHAIRMAN: CLAUDIO LOMBARDO, ANTONIO LLOMBART BOSCH
10.20 – 11.00
BUILDING THE EUROPEAN AREA FOR CANCER RESEARCH
Claudio Lombardo
Special Assistant to the OECI President – National Institute for Cancer research of Genoa – Italy11.00 – 11.40
IMMUNOHISTOCHEMISTRY OF THE NEW MOLECULAR CLASSIFICATION OF BREAST CARCINOMA
Antonio Llombart Bosch, Isidro Machado, Antonio Llombart Cussac
Dpt. Pathology. University of Valencia and Dpt. Oncology Hosp. Arnau Vilanova Lleida, Spain11.40 – 12.20
MANAGEMENT OF SOFT TISSUE TUMOR SPECIMENS IN THE PATHOLOGY DEPARTMENT: PRACTICAL CONSEQUENCES
FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH SARCOMAS
Philippe Terrier
Institute Gustave Roussy, Villejuif, France
12.20 – 14.20 LUNCH TIME / POSTER SESSION 1 PATHOLOGY POSTER SESSION/CHAIRMAN: PHILIPPE TERRIER,
JOSÉ ANTONIO LÓPEZ-GUERRERO, RARES BUIGA - POSTER VIEWING
HISTOPATHOLOGICAL ASPECTS IN UTERIN CERVICAL CANCER1.
Izabella Sargan, Elena Pop, Roxana Folescu, Anca Muresan, Paul Ionut Stanciu, Stelian Pantea
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania
3
HISTOPATHOLOGICAL ASPECTS IN THYROID CANCER2.
Izabella Sargan, Elena Pop, Roxana Folescu, Anca Muresan, Paul Ionut Stanciu, Stelian Pantea
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaHISTOLOGICAL ASPECT IN COLORECTAL CANCER3.
Roxana Folescu, Elena Pop, Izabella Sargan, Paul Ionut Stanciu, Stelian Pantea, Anca Muresan, Ecaterina Daescu
“Victor Babeş” University of Medicine and Pharmacy Timişoara, RomaniaQUANTIFYING INVASION GROUPS MEDIASTINAL LYMPH NODES IN LUNG CANCER4.
Roxana Folescu, Elena Pop, Izabella Sargan, Paul Ionut Stanciu, Stelian Pantea, Anca Muresan, Ecaterina Daescu
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaPATHOLOGIC ANATOMICAL ASPECTS OF MALIGNANT OVARIAN TUMORS5.
Elena Pop, Izabella Sargan, Roxana Folescu, Paul Ionut Stanciu, Stelian Pantea, Alexandra Pop
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaENDOMETRIOID CARCINOMA6.
Elena Pop, Izabella Sargan, Roxana Folescu, Paul Ionut Stanciu, Stelian Pantea, Alexandra Pop
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaOVARIAN TUMORS OF MALIGNANCY LIMIT7.
Paul Ionut Stanciu, Stelian Pantea, Elena Pop, Roxana Folescu, Anca Muresan, Izabella Sargan
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaTHE PREVALENCE OF TUMORAL SKIN MELANOCYTIC LESSIONS IN CHILDREN: A RETROSPECTIVE STUDY ON 58 8.
CASES
Loredana Beatrice Ungureanu1, Doina Mihaila2, Petru Plamadeala2, Mioara Trandafi rescu1, Adana Varna3
1University of Medicine and Farmacy “Gr. T. Popa” Iaşi, Morphopathology Department 2“St. Mary” Emergency Hospital for Children Iaşi, Pathology Laboratory 3City Hospital Tg. Frumos
USEFUL IMMUNOHISTOCHEMICAL TECHNIQUES FOR ELUCIDATING MINUTE ATYPICAL GLANDULAR9.
PROLIFERATIONS IN PROSTATE BIOPSY SPECIMENS – PRELIMINARY RESULTS
Alis Dema1, Denisa Anderco2, Sorina Taban1, Elena Lazar1, Maria Cornianu1, Codruta Lazureanu1, Diana Herman2, Anca
Muresan1, Remus Cornea1, Alexandra Faur1
1“Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania2Emergency County Hospital, Timişoara, Romania
CHANGING OF THE IMMUNOHISTOCHEMICAL PROFILE OF THE BREAST CANCER CELLS DURING CHEMOTHERAPY:10.
A TREATMENT CHALLENGE
Codruţa Lazureanu1,2, Elena Lazar1,2, Alis Dema1,3, Diana Herman3, Remus Cornea1
1 “Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania2City Hospital Timişoara 3County Hospital Timişoara
PLEOMORPHIC SARCOMA OF SOFT TISSUE WITH GIANT CELLS, AS IMUNOPHENOTIPICAL SYNOVIAL SARCOMA11.
Eugenia Moldovan, Anca Paulet, Jung Janos
Târgu Mureş County Emergency HospitalRELATIONSHIP BETWEEN CYCLOOXYGENASE – 2 EXPRESSION AND ANGIOGENESIS IN PATIENTS WITH GASTRIC 12.
CANCER
Sorina Taban, Daniela Lazar, Alis Dema, Elena Lazar, Marioara Cornianu, Codruta Lazureanu
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaIMMUNOHISTOCHEMICAL EXPRESSION OF KI-67, P53 AND CYCLOOXYGENASE-2 IN GASTRIC CARCINOMA: 13.
CORRELATION WITH CLINICOPATHOLOGICAL FACTORS AND SURVIVAL
Sorina Taban, Daniela Lazar, Alis Dema, Elena Lazar, Marioara Cornianu, Alexandra Faur, Cornea R., Mirela Grigoras,
Delia Zahoi
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania
PLENARY SESSION 2 / CHAIRMAN: KRISTIN HENRY, ELIAS CAMPO
14.20 – 15.00
LYMPHOMA DIAGNOSIS FROM MORPHOLOGY TO MOLECULAR GENETICS
Elias Campo
Hospital Clinic, University of Barcelona, Barcelona, Spain15.00 – 15.40
DENDRITIC CELL TUMOURS
Kristin Henry
Imperial College London, Charing Cross Hospital, London W6 8RF15.40 – 16.10
PATHOBIOLOGY VS. RADIOBIOLOGY IN CANCER TREATMENT: FOCUS ON RADIOGENOMICS
V. Cernea
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania
16.10 – 16.20 / COFFEE BREAK
4
16.20 – 16.50
CIRCULATING TUMOR CELLS DETECTION IN BREAST AND GYNECOLOGIC CANCERS
Rares Buiga
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania16.50 – 17.20
BLOOD ANGIOGENIC MARKERS AS NONINVASIVE DIAGNOSIS IN PROSTATE CANCER
Ovidiu Balacescu1, Oana Tudoran1, Loredana Balacescu1, Claudia Burz2, Nicolae Crisan3, Sorin Popescu1, Alexandru
Irimie1,2, Neagoe Ioana1,2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania3County Hospital Cluj-Napoca17.20 – 17.50
CASTLEMAN’S DISEASE
Bogdan Fetica, Anca Popa, Alin Rancea, Andrei Cucuianu
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania
19.30 – GALA DINNER – MARCO POLO RESTAURANT AT CITY PLAZA
THURSDAY, APRIL 29, 2010
PLENARY SESSION 3/CHAIRMAN: JOSÉ ANTONIO LÓPEZ-GUERRERO, GEORGE KONTOGEORGOS
9.00 – 9.40
MOLECULAR STAGING OF PROSTATE CANCER: THE ROLE OF THE NEW BIOMARKERS
José Antonio López-Guerrero
Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología Valencia, Spain9.40 – 10.20
RENAL CELL CARCINOMAS IN PATIENTS WITH RADIATION EXPOSURE FOLLOWING THE CHERNOBYL ACCIDENT
Antonio Llombart Bosch, Alina Romanenko,* Luisa Morell, José Antonio López-Guerrero**
Dpt. Pathology, Univ. Valencia, Spain, *Departments of Pathology and Urology, Institute of Urology, Academy of Medical Sciences, Kiev, Ukraine, **Molecular Biology Service IVO Valencia, Spain 10.20 – 10.50
MODERN APPROACH IN THE PATHOLOGY OF PROSTATE ADENOCARCINOMA
Petre Florescu
“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
10.50 – 11.00 / COFFEE BREAK
11.00 – 11.40
GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS)
George Kontogeorgos M.D., Ph.D.
Department of Pathology and Pituitary Tumor Reference Center, G. Gennimatas Athens General Hospital, Athens, Hellas 11.40 – 12.10
CRYOGLOBULINEMIC GLOMERULONEPHRITIS: CLINICO-BIOPTIC CORRELATIONS
C. Spanu1, P. Florescu1, Anca Cristea2, C. Craciun3
1“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania2County Hospital Cluj-Napoca3”Babeş-Bolyai” University, Cluj-Napoca, Romania12.10 – 12.50
APPLICATION OF ENDOSOMOLYTIC CELL-PENETRATING PEPTIDES FOR NUCLEIC ACID DELIVERY- APPLICATIONS AND
POTENTIAL IMPLICATION FOR CANCER TREATMENT
Samir EL Andaloussi1,3, Taavi Lehto2, Iulian Oprea3, CI Edvard Smith3 and Ülo Langel1,2
1Stockholm University, Department of Neurochemistry, 106 92 Stockholm, Sweden2Tartu University, Institute of Technology, 504 11 Tartu, Estonia3Karolinska Institute, Department of Laboratory Medicine, 141 86 Huddinge, Sweden
5
12.50 – 13.20
LYMPHANGIOGENESIS AS A POTENTIAL MARKER FOR TUMOR THERAPY
Marius Raica, Anca Maria Cimpean
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, Romania
13.20 – 14.40 LUNCH TIME/ POSTER SESSION 2 MOLECULAR BIOLOGY POSTER SESSION/CHAIRMAN:
CLAUDIO LOMBARDO, SAMIR EL ANDALOUSSI, IOANA NEAGOE - POSTER VIEWING
ANTIOXIDANT1. EFFECTS OF A GRAPE SEED EXTRACT (GSE)
Gabriela Chereches1, Corina Tatomir1, Doina Daicoviciu2, I.D. Postescu1
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
L-N-ACETYLCYSTEINE AGAINST AMINOGLYCOSIDES’ OTOTOXICITY IN THE ORGAN CULTURES OF RAT COCHLEA2.
Maria Perde-Schreppler1, Alma Maniu2, Marcel Cosgarea2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
MECHANISMS OF APOPTOSIS INDUCED BY OXALIPLATIN IN COLORECTAL CANCER. PHARMACOGENOMICS STUDY3.
Claudia Burz1, Ovidiu Balacescu2, Oana Tudoran2, Loredana Balacescu2, Victor Cristea1, Sorin E. Leucuta1, Alexandru
Irimie1,2, Ioana Neagoe1,2
1“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania2“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania4. ARSENIC TRIOXIDE SENSITIZES CANCER STEM CELLS TO CONVENTIONAL CHEMOTHERAPY – A DIFFERENTIATION
THERAPY MODEL FOR HEPATOCELLULAR CARCINOMA
Ciprian Tomuleasa1·2, Olga Soritau1, Teodora Pop2·3, Eva Fischer-Fodor1, Ofelia Mosteanu2·3, Bogdan Pintea3, Piroska
Virag1, Gabriel Kacso1·2, Monica Acalovschi2·3, Alexandru Irimie1,2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania33rd Medical Clinic, Cluj Napoca
APOPTOSIS INDUCED PATHWAYS BY RNA INTERFERENCE VEGF INHIBITION IN CERVICAL CANCER5.
O. Tudoran1,2, C. Braicu1, O. Soritau1, O. Balacescu1, L. Balacescu1, F. Irimie2, I. Neagoe 1,3
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2Faculty of Chemistry and Chemical Engineering3“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
p53 GENE THERAPY IN HUMAN CERVICAL CANCER CELL LINE6.
Cornelia Braicu1, Ioana Berindan Neagoe1,2, Roxana Redis2, Oana Tudoran1, Ovidiu Balacescu1, Alexandru Irimie1,2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
TEMOZOLOMIDE ENHANCE NEOANGIOGENESIS OF GLIOBLASTOMA MULTIFORME IN A 3D ANGIOGENESIS ASSAY7.
Vasile Foris1, 2, Ciprian Tomuleasa1, 2, Olga Soritau1 , Dana Cernea1, Horatiu Ioani3, Stefan Florian 2,3
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania3Neurosurgery Clinic, Cluj County Hospital
PLACENTAL MESENCHYMAL STEM CELLS DIFFERENTIATION8.
Dan Rus Ciuca1, Olga Soritau2, Sergiu Susman3, Victor Pop4, Carmen Mihu3
1Emergency County Clinic Hospital Cluj-Napoca2“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania3“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
A STATIC CYTOMETRIC EVALUATION OF THE 9. EX VIVO TUMORAL CHEMOSENSITIVITY TO PLATINUM-BASED DRUGS
Eva Fischer-Fodor1, Olga Soritau1, Piroska Virag1, Rares Buiga1, Doris Pelau1, Cosmin Lisencu1, Otilia Barbos1, Natalia
Miklasova2, Yael Schiff enbauer3, Alexandru Irimie1
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2Faculty of Pharmacy, Comenius University in Bratislava, Slovakia3Cell Kinetics Laboratory, Lod, Israel
FUNCTIONAL GENOMICS STUDY IN PROSTATE CANCER10.
Loredana Balacescu1,3, Ovidiu Balacescu1, Nicolae Crisan2, Oana Tudoran1, Meda Rus1, Claudia Gherman1, Cornelia
Braicu1, Nicoale Dragos3, Ioana Neagoe1,4
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2Municipal Clinical Hospital, Cluj-Napoca, Romania3Faculty of Biology, “Babeş-Bolyai” University, Cluj-Napoca, Romania4“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
THE UTILITY OF FUNCTIONAL GENOMICS TECHNOLOGIES IN EXPERIMENTAL MODELS FOR CANCER RESEARCH11.
Claudia Gherman1, Cornelia Braicu1, Loredana Balacescu1, Ovidiu Balacescu1, Oana Tudoran1, Flaviu Dragla1, Gheorghe
Rapuntean3, Ioana Neagoe1,2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania3University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania
6
MONITORING T315I MUTATION IN CHRONIC MYELOID LEUKEMIA BY ARMS PCR12.
D. Dima1, Trifa A.2, A. Cucuianu1, R.A. Popp2, M. Patiu1, L. Petrov1
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
THE13. JAK2 RS10974944 SNP, PART OF JAK2 46/1 HAPLOTYPE, IS STRONGLY ASSOCIATED WITH JAK2 V617F -
POSITIVE MYELOPROLIFERATIVE NEOPLASMS
Adrian P. Trifa1, Andrei Cucuianu2, Ljubomir Petrov2, Laura Urian2, Mariela Militaru1, Delia Dima2, Ioan V. Pop1, R.A.
Popp1
1“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania2“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania14. DNA METHYLATION IN CANCER
Roxana Redis2, Ovidiu Balacescu1, Ioana Neagoe1,2, Victor Ioan Pop2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
PLENARY SESSION 4/CHAIRMAN: PETRE FLORESCU, EUGEN MANDACHE
14.40 – 15.00
MICRODISSECTION FROM CARL ZEISS: A NEW DIMENSION IN SAMPLE PURITY
Antje M. Pries, Carl Zeiss A.G., Germany15.00 – 15.30
IMMUNO-HISTOPATHOLOGICAL FEATURES IN HUMAN AND EXPERIMENTAL DIABETIC NEPHROPATHY
E. Mandache, M. Penescu
“Carol Davila” Clinical Hospital of Nephrology – Bucharest, “Victor Babeş” National Institute of Pathology – Bucharest15.30 – 16.00
THE ROLE OF THE BIOPSY IN PULMONARY PEDIATRIC PATHOLOGY
D. Gheban1, P. Florescu2, Bianca Urzica2
1Pediatric Emergency Hospital Cluj-Napoca2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania16.00 – 16.30
BORDERLINE OVARIAN LESIONS
Patriciu Achimas Cadariu1,2, Cosmin Lisencu1, Ioana Berindan Neagoe1,2, Rares Buiga, Emilian Neagoe1, Emil Puscas2,
Alexandru Irimie1,2
1 “Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
16.30 – 16.40 / COFFEE BREAK
16.40 – 17.10
VALIDATION OF NEW BIOMARKERS FOR CANCER THERAPY
Ioana Berindan Neagoe1,2, Ovidiu Balacescu1, Loredana Balacescu1, Oana Tudoran1, Claudia Burz2, Rares Buiga1, Patriciu
Achimas Cadariu1,2, Alexandru Irimie1,2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2University of Medicine and Pharmacy Cluj Napoca17.10 – 17.40
CYTOTOXICITY AND CYTOGENETIC FEATURES OF OXALIPLATIN RESISTANT COLORECTAL CANCER CELL LINE
Piroska Virag, Eva Fischer-Fodor, Maria Perde-Schreppler, Ioana Brie, Corina Tatomir
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania17.40 – 18.10
PREDICTION OF CLINICAL OUTCOME IN PATIENTS WITH CERVIX CARCINOMA BY PRE-THERAPEUTIC EVALUATION OF
DNA LESIONS
Ioana-Carmen Brie, Viorica Nagy, Piroska Virag, Maria Perde-Schreppler, Eva Fisher-Fodor, Vasile Foris, Nicolae Todor
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania
DOCTOR HONORIS CAUSA CEREMONY FOR PROF. ANTONIO LLOMBART BOSCH
AT “IULIU HAŢIEGANU” UNIVERSITY OF MEDICINE AND PHARMACY CLUJ-NAPOCA (HOUR TO BE ANNOUNCED)
19.00 DINNER – CHIOS RESTAURANT
7
FRIDAY, APRIL 30, 2010
9.00 – 10.50 / SLIDE SEMINAR – FIRST SESSION
Note: each case shall be presented in maximum 10 minutes, following the next scheme: brief clinical context, important points for diagnosis, diagnosis, diff erentials.The organizers off ers an important number of microscopes to be used by the participants as well as a telepathology system (slidesshall be available on a web link before the conference) to give access to the specifi c cases involved in the seminar.
Case n° 1 – KRISTIN HENRY
Case n° 2 – KRISTIN HENRY
Case n° 3 – PETRE FLORESCU
Case n° 4 – ANTONIO LLOMBART-BOSCH
Case n° 5 – ANTONIO LLOMBART-BOSCH
Case n° 6 – MARIUS RAICA
Case n° 7 – PHILIPPE TERRIER
Case n° 8 – PHILIPPE TERRIER
Case n° 9 – ELIAS CAMPO
Case n° 10 – ELIAS CAMPO
10.50 – 11.00 / COFFEE BREAK
11.00 – 13.00 / SLIDE SEMINAR – SECOND SESSION
Case n° 11 – MARIA SAJIN
Case n° 12 – GEORGE KONTOGEORGOS
Case n° 13 – GEORGE KONTOGEORGOS
Case n° 14 – JUNG JANOS
Case n° 15 – JOSÉ ANTONIO LÓPEZ-GUERRERO
Case n° 16 – JOSÉ ANTONIO LÓPEZ-GUERRERO
Case n° 17 – EUGEN MANDACHE
Case n° 18 – DAN GHEBAN
Case n° 19 – RARES BUIGA
Case n° 20 – BOGDAN FETICA
13.00 – 15.00 LUNCH TIME/ POSTER SESSION 3 CLINICAL POSTER SESSION/CHAIRMAN: ELIAS CAMPO,
GEORGE KONTOGEORGOS, PATRICIU ACHIMAS - POSTER VIEWING
SPORADIC COLORECTAL CANCER OR HEREDITARY LYNCH SYNDROME: ANAMNESTIC EPIDEMIOLOGIC STUDY1.
USING AMSTERDAM AND BETHESDA CRITERIA
Simona Valean1, P.A. Mircea1, Doinita Crisan2, Magda Petrescu2
“Iuliu Haţieganu” University of Medicine and Pharmacy of Cluj-Napoca, RomaniaHOW TO BOOST THE BREAST TUMOR BED? FROM CONVENTIONAL TO 3D-CONFORMAL IN EARLY BREAST CANCER 2.
RADIOTHERAPY IN “PROF. DR. ION CHIRICUŢĂ” ONCOLOGY INSTITUTE RADIOTHERAPY DEPARTMENT
Daniela Martin, Cristina Vitoc, Gabriela Tufascu, V. Bogdan, D. Dordai, A. Chis, Carmen Lisencu, Cosmin Lisencu, A.
Rancea, R. Tanasescu, Carmen Popa, Dana Grecea, V. Cernea, N. Ghilezan
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, RomaniaLAPAROSCOPY – MODERN TREATMENT IN CERVICAL CANCER3.
Paul Ionut Stanciu, Stelian Pantea, Elena Pop, Roxana Folescu, Anca Muresan, Izabella Sargan
“Victor Babeş” University of Medicine and Pharmacy, Timişoara, RomaniaPHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. THE EXPERIENCE OF HEMATOLOGY CLINIC CLUJ-4.
NAPOCA
Delia Dima1, Andrei Cucuianu1, Mariana Patiu1, Ljubomir Petrov1, Hartmut Dohner2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania, Hematology Department2University of Ulm, Department of Internal Medecine III, Ulm, Germany
8
ACUTE MYELOID LEUKEMIA AND TYPE II DIABETES MELLITUS IN COMPLETE REMISSION AFTER ALLOGENEIC STEM 5.
CELL TRANSPLANTATION
Delia Dima1, Andrei Cucuianu1, Smaranda Arghirescu2
1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2„Louis Turcanu” Children’s Hospital Timişoara, Bone Marrow Transplantation Department
RISK FACTORS FOR INEFFECTIVE COPING IN ACUTE LEUKEMIA PATIENTS6.
Andrada Parvu
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, RomaniaTHE TREATMENT WITH BORTEZOMIB IN MULTIPLE MYELOMA7.
Anca Bojan, Anca Vasilache, A. Cucuianu, Laura Urian, Mariana Patiu, Carmen Basarab, C. Coldea, Tunde Torok, M.
Zdrenghea, L. Petrov1“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania2“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
UNUSUALLY LONG LASTING HEMATOLOGICAL REMISSION AND SURVIVAL IN A CASE OF CHRONIC MYELOID8.
LEUKEMIA TREATED WITH THREE DIFFERENT THYROSINE KINASE INHIBITORS.
L. Petrov, Laura Urian, Anca Vasilache, Anca Bojan, A. Cucuianu, Mariana Patiu, Carmen Basarab, C. Coldea
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania & “Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
MABTHERA IN TREATMENT OF NONHODGKIN LYMPHOMAS- PRESENTATION OF 27 CASES TREATED AT9.
HEMATOLOGY CLINICS CLUJ NAPOCA BETWEEN 2001 – 2009
Tunde Torok-Vistai, L. Petrov, A. Cucuianu, A. Bojan, L.Urian, A. Vasilache, M. Zdrenghea, A. Zsoldos
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, RomaniaUNUSUAL ALTERNATIVE OF RICHTER SYNDROM: HODGKIN LYMPHOMA.10.
Laura Urian, Ljubomir Petrov, Cosmina Gavrilut, Anca Bojan, Carmen Basarab, Andrei Cucuianu, Mariana Patiu, Tunde
Torok, Anca Vasilache, Mihnea Zdrenghea
“Iuliu Haţieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania
DEVELOPING A PREDICTIVE MODEL FOR TRANSFUSION REQUIREMENT FOR ACUTE LEUKEMIA PATIENTS11.
Andrada Parvu, Anca Bojan, Andrei Cucuianu, Laura Urian, Anca Vasilache, Tunde Torok, Mihnea Zdrenghea, Mariana
Patiu, Carmen Basarab, Delia Dima, Cosmina Gavrilut, Mihaela Grosan, Alina Cuc, Andrea Zsoldos, Anca Daniela, Mihai
Chirila, Ionel Rosu, Ljubomir Petrov
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca, Romania
15.00 – 15.30 – CLOSING CEREMONY – DIPLOMA’S AWARD
ORGANISING COMMITTEE:
ALEXANDRU IRIMIE
ANTONIO LLOMBART BOSCH
IOANA NEAGOE
RARES BUIGA
VALENTIN CERNEA
PETRE FLORESCU
MARIA SAJIN
PATRICIU ACHIMAS CADARIU
SPONSORS:
Recommended